Form D · Biotechnology
Repair Biotechnologies, Inc.
Syracuse, NY · CIK 0001750699
Offering snapshot reported Nov 25, 2025 · SEC filing
- Reported sold
- $5.26M Offering amount: $11M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2025 | Initial | $5,258,906 | No comparison | 16 | SEC filing |
| Mar 26, 2024 | Initial | $6,166,000 | No comparison | 7 | SEC filing |
| Jun 16, 2023 | Initial | $8,389,479 | No comparison | 38 | SEC filing |
| Feb 23, 2021 | Initial | $200,000 | No comparison | 2 | SEC filing |
| Sep 1, 2020 | Initial | $2,855,000 | No comparison | 13 | SEC filing |
| May 7, 2019 | Amendment | $2,150,000 | $880,000vs Mar 25, 2019 | 15 | SEC filing |
| Mar 25, 2019 | Initial | $1,270,000 | No comparison | 8 | SEC filing |
| Jan 23, 2019 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Aug 21, 2018 | Initial | $450,000 | No comparison | 6 | SEC filing |
| Aug 21, 2018 | Amendment | $450,000 | $0vs Aug 21, 2018 | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-564986
Source: Form D, filed Nov 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guilherme Cherman Perdigao De Oliveira | Director, Executive |
| Guilherme Cherman Perdig?O De Oliveira | Director |
| Anthony Matthew Chow | Director |
| Kelsey Moody | Director |
| Reason N/A | Director, Executive |
| Guilherme Cherman Perdigao De Oliveira | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
841 E Fayette Street
Syracuse, NY, 13210
Syracuse, NY, 13210